Malignant Chondroblastoma of the Os Calcis by Elek, Emil M. et al.
Sarcoma (1998) 2, 45± 48
CASE REPORT
Malignant chondroblastoma of the os calcis
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Abstract
Patient. We describe a case of chondroblastoma of the os calcis which metastasized to the tibia, soft tissues and lung. A
complete response of the lung lesions was noted with chemotherapy.
Discussion. Review of the published literature shows that metastatic chondroblastoma only arises following local
recurrence of the tumour.
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Introduction
Chondroblastomas are recognized as benign pri-
mary bony lesions, ® rst described as a distinct entity
by Jaffe and Lichtenstein in 1942.
1
These are rare tumours, the incidence being less
than 1% of all primary bone tumours.
2,3 Males are
affected more often than females, the ratio being
approximately 1.7; 1.
2 Chondroblastomas are usu-
ally located in the epiphysis and are most commonly
diagnosed in the second decade, while the epiphy-
seal plate is still open.
2,4
The most common sites are the proximal
humerus, femur and proximal tibia. They occur less
frequently around the ankle or in association with
the apophyses.
2± 4
The radiological features are fairly typical: a lytic
lesion arising in the epiphysis with an eccentric
location, mostly without periosteal reaction. The
lesion usually involves less than half of the epiphysis
and has a thin sclerotic border.
2,3 Clinically, patients
present with pain, swelling around the joint and a
limited range of movements due to pain. At a later
stage, the tumour could be associated with a synovi-
tis and a joint effusion. Histologically the tumour is
built up of round or polygonal chondroblasts sur-
rounded by reticulin ® bres. The matrix is pink-
stained chondroid, with occasional focal
calci® cation. Scattered osteoclast-type multi-nucle-
ated cells are often present.
2,3
The usual treatment is simple curettage of the
lesion, with occasional bone grafting. Most authors
agree that, with intralesional curettage of the
tumour, the local recurrence rate is between 5 and
16%.
2,4 Only a few cases have been reported in the
literature
5± 15 which have metastasized to the lungs,
other bones or soft tissues.
In this report, we present the case of a 12-year-old
boy with a chondroblastoma of the os calcis. Fol-
lowing surgical treatment the tumour behaved in a
malignant manner, with a local recurrence and
metastatic disease.
Case history
In March 1995, a 12-year-old boy was referred to
our unit with a 3-month history of pain and swelling
of his right ankle region. Radiographs revealed a
lytic expansile lesion of the os calcis containing
calci® cation (Fig. 1). Biopsy was carried out prior to
referral and histology was consistent with a chon-
droblastoma. A careful curettage was performed
with burring and brushing of the walls of the cavity
and pulsed lavage irrigation.
Histology of the curettage specimen showed some
necrotic areas and discrete reactive changes due to
the previous biopsy, but was fully consistent with
chondroblastoma.
Review at 6 weeks was satisfactory with absence
of pain or swelling and radiographs showed some
early signs of consolidation of the os calcis. Three
months later the patient returned with further swell-
ing and pain of the hind foot, with limitation of
movements of the ankle and subtalar joints. Radio-
graphs now showed total destruction of the os calcis
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Fig. 1. Lateral radiograph of ankle and hindfoot showing a
lytic expansile lesion of the calcaneus containing some cartilage
mineralization.
Fig. 2. Sagittal T1-weighted magnetic resonance image of the
hindfoot 4
1
2 months after curettage showing extensive in® ltration
of the calcaneus by recurrent tumour.
identical to the appearances of the previous biopsies.
Further scans (computed tomography (CT) chest
and Tc isotope bone scan) excluded the presence of
any other secondary tumours. An above knee ampu-
tation was performed.
Histology of the amputation specimen con® rmed
secondary lesions in the peroneal muscles and sev-
eral places in the soft tissues of the amputated leg.
Histology of each tumour foci was identical to the
former biopsies (Fig. 4).
He was restaged 12 weeks later following the
amputation when CT scans revealed the presence of
lung metastases. In view of this, he was treated with
chemotherapy (cisplatin 100 mg m
2 2 and doxoru-
bicin 75 mg m
2 2) and after six cycles there was
complete resolution of the lung disease. He re-
mained disease free for over 12 months before re-
lapsing with further pulmonary disease. This was
resected surgically and histology again showed
identical ® ndings to the previous lesions in the leg.
He has had post-operative whole-lung radiotherapy
and remains alive and symptom free 3 years from
diagnosis.
Discussion
Since Jaffe and Lichtenstein ® rst described chon-
and magnetic resonance imaging (MRI) revealed
dramatic extension of the lesion into soft tissues and
adjacent bones (Fig. 2). Chest X-ray was normal
and a repeat biopsy was performed.
All previous histology slides were reviewed to-
gether with the new specimens. Typical chondrob-
lasts were seen in a rich chondroid matrix (Fig. 3).
A fairly high mitotic activity (more than 10 mitoses
per high-power ® eld) was also seen along with un-
usual extended necrotic zones. The specimens were
reviewed by pathologists in the UK and the US and
the consensus was that the recurrent lesion was
consistent with a diagnosis of chondroblastoma with
atypical features.
As no reconstruction was felt possible the patient
was prepared for a below-knee amputation. On ad-
mission for this procedure the patient complained of
shin pain, and radiographs and MRI now revealed
two lytic lesions in his right tibia and a soft tissue
mass in the right calf. Biopsy of these lesions was
carried out and all the lesions were histologically
Fig. 3. High power view of primary tumour showing areas
of pink chondroid, polygonal `chondroblast’ tumour cells with
folded and clefted nuclei and osteoclast-like giant cells.
Fig. 4. High power view of recurrent tumour in the calf
showing identical features to the original tumour.Chondroblastoma of the os calcis 47
Table 1. Details of reported cases of `metastatic’ chondroblastoma
Local Time to Treatment of
Author Age Site recurrence? metastases metastases Result
Kahn, 1969
8 13 Pelvis Yes 3 4 9 years Nil Death 6 years
Wellman, 1969
15 17 Scapula Yes 25 years Thoracotomy Alive 1 year
Riddell, 1973
10 14 Tibia Yes 2 years Thoracotomy Alive 9 years
Green, 1975
5 13 Prox. femur Yes 2 years Biopsy only Alive 2 years
Huvos, 1977
7 16 Distal femur Yes 1 year Thoracotomy Alive 6 years
Wirman, 1979
14 38 Scapula Yes 33 years Nil Death 9 months
Sabek, 1982* 28 Talus Yes 3 years Not recorded Not recorded
Donovan, 1982* 15 Distal femur Yes 1 year Thoracotomy Alive 5 years
Kunze, 1987
13 33 Pelvis No** 13 years Thoracotomy Alive 6 years
van Horn, 1990
12 38 Distal femur Yes 11 years Thoracotomy Alive 1 year
Elek, 1998 12 Os calcis Yes 3 months Chemotherapy Alive 3 years
*These patients both quoted in paper of Kyriakos et al.
9
**This patienthad a hindquarter amputation following a misdiagnosis of chondrosarcoma but the tumour was subsequently
reclassi® ed as chondroblastoma.
droblastoma, several hundred cases have been
reported, the vast majority of them con® rming that
the lesion is clinically benign.
Only a few cases have been reported where,
despite the benign histological appearance, the
tumour behaved aggressively, occasionally metasta-
sizing to neighbouring or distal bones, soft tissues,
or more often the lungs.
5± 13 In Sirsat’s case
11 the
tumour changed to a frankly malignant
® brosarcoma but in all the others the histological
appearance of the metastases was identical to the
primary tumour.
There appears to be some confusion in the litera-
ture about the name malignant chondroblastoma.
Some authors consider locally aggressive chondrob-
lastomas to be malignant forms, although there was
no evidence of metastasis of the tumour.
1 There is a
report of a case where a histologically benign look-
ing chondroblastoma progressively increased in size
with secondary spread to the lungs, but following




2,7 suggest that these lung
metastases represent self-limited `transplants’ or
`implants’, and suggest the term `benign’ metasta-
sis. Kyriakos et al.
9 suggest the name `metastasizing
chondroblastoma’, rather than malignant chondrob-
lastoma, for these cases.
All the reported cases of con® rmed metastatic
lesions to the lungs where the histological appear-
ance of the metastases was identical with the pri-
mary tumour are identi® ed in Table 1. The single
common feature of all these cases is that the metas-
tases only developed if there had been a previous
local recurrence of the primary tumour. The age
and site of the tumours correspond with the normal
distribution of chondroblastomas. The only case
where there was not a local recurrence was where
the primary tumour had clearly been overtreated by
a hindquarter amputation after a biopsy had (incor-
rectly) been interpreted as a chondrosarcoma.
13
The treatment of the metastases has varied. In
some cases the multiplicity of the lesions led to a
lack of treatment and was followed by death. In
other cases, thoracotomy has produced apparent
long-term cures, while in other cases the lesions
have remained static following simple biopsy.
Clearly, the biological behaviour of these metastatic
tumours is unpredictable and is remarkably similar
to that seen in metastatic giant cell tumours.
16
Chondroblastomas represent less than 1% of all
bone tumours and the number of patients with
documented metastases is less than 1% of all
reported cases of chondroblastoma in the world
literature. The risk of metastases developing in
chondroblastoma is clearly lowÐ and probably
much less than 1% of all of these tumours.
From our review of the literature, we conclude
that:
(1) Lung metastases have only been reported fol-
lowing local recurrence of the tumour (unless
the patient has had an amputation).
(2) Full staging with chest radiographs and/or CT
scan of the chest is advisable in any locally
recurrent chondroblastoma. Bone scintigraphy
and MRI will also be required to exclude spread
to other bones or soft tissues, respectively.
(3) In the presence of rapidly progressive chon-
droblastoma, chemotherapy may be indicated.
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